Pulse Biosciences (PLSE) Valuation Check After Strong Recent Share Price Momentum

Simply Wall St.05-30

AdvertisementWhat recent performance tells you about Pulse Biosciences stock Pulse Biosciences (PLSE) has drawn attention after a period of strong share price moves, with the stock up about 24% over ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2639603100?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-05-30 08:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2639603100","market":"us","top_or_hot":-1,"title":"Pulse Biosciences (PLSE) Valuation Check After Strong Recent Share Price Momentum","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhat recent performance tells you about Pulse Biosciences stock Pulse Biosciences (PLSE) has drawn attention after a period of strong share price moves, with the stock up about 24% over ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/pulse-biosciences-plse-valuation-check-after-strong-recent-s\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pulse Biosciences (PLSE) Valuation Check After Strong Recent Share Price Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPulse Biosciences (PLSE) Valuation Check After Strong Recent Share Price Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-30 08:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/pulse-biosciences-plse-valuation-check-after-strong-recent-s><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhat recent performance tells you about Pulse Biosciences stock Pulse Biosciences (PLSE) has drawn attention after a period of strong share price moves, with the stock up about 24% over ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/pulse-biosciences-plse-valuation-check-after-strong-recent-s\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PLSE","symbol_name":"Pulse Biosciences, Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/pulse-biosciences-plse-valuation-check-after-strong-recent-s","article_id":"2639603100","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/pulse-biosciences-plse-valuation-check-after-strong-recent-s","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2639603100","pubTimestamp":1780100110,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"What recent performance tells you about Pulse Biosciences stock\nPulse Biosciences (PLSE) has drawn attention after a period of strong share price moves, with the stock up about 24% over the past month and about 34% over the past 3 months.\nFor context, the Miami based bioelectric medicine company has a market value of about US$1.71b and focuses on its nPulse system platform across dermatology and cardiac applications, an area many investors track closely in the healthcare segment.\nSee our...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"PLSE":"Pulse Biosciences, Inc.","BK4082":"医疗保健设备"},"translate_title":"Pulse Biosciences(PLSE)近期股价势头强劲后进行估值检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PLSE":1.5},"content_text":"AdvertisementWhat recent performance tells you about Pulse Biosciences stock Pulse Biosciences (PLSE) has drawn attention after a period of strong share price moves, with the stock up about 24% over the past month and about 34% over the past 3 months. For context, the Miami based bioelectric medicine company has a market value of about US$1.71b and focuses on its nPulse system platform across dermatology and cardiac applications, an area many investors track closely in the healthcare segment. See our latest analysis for Pulse Biosciences. At a share price of US$25.01, Pulse Biosciences has seen strong recent momentum, with an 86.78% year to date share price return and a 290.78% three year total shareholder return. This comes even though the 7 day share price return is down 3.40%, which can reflect shifting expectations around growth prospects and risk. If you are looking for other fast moving healthcare names with potential growth stories, it can be useful to scan beyond a single stock using our screener for 37 healthcare AI stocks With the stock up strongly over recent periods, trading around US$25.01 and sitting below an average analyst price target of US$30.00, the question becomes whether Pulse Biosciences is still undervalued or if the market is already pricing in future growth. Most Popular Narrative: 13.7% Overvalued According to the most followed narrative, Pulse Biosciences has a fair value of $22 per share compared with the recent price of $25.01, which puts expectations in focus.  Advancing clinical programs for the nPulse cardiac surgical clamp and nPulse 360 Catheter in atrial fibrillation, including FDA IDE approval, breakthrough designation, and expanding EU feasibility data, creates a path to entry in a high value EP and cardiac surgery market that can expand the company’s addressable revenue base and long term earnings power.  Read the complete narrative. Want to see what kind of revenue ramp, margin shift, and valuation multiple that narrative is baking in, and how those pieces fit together over time? Result: Fair Value of $22 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there are still clear risks, including limited current revenue relative to high quarterly costs, as well as the possibility that clinical or reimbursement outcomes fall short of expectations. Find out about the key risks to this Pulse Biosciences narrative. Next Steps With all this in mind, do you think the optimism outweighs the concerns, or the other way around? Act quickly, review the key data points yourself, and then weigh both sides with a closer look at the 1 key reward and 3 important warning signs Looking for more investment ideas? If you stop at just one stock, you risk missing other opportunities that might suit your goals even better, so put a few strong alternatives on your radar.  Target potential mispricings by scanning a focused set of 46 high quality undervalued stocks that pair quality fundamentals with price tags that may warrant a closer look. Prioritise resilience by checking out 62 resilient stocks with low risk scores that score well on stability so short term shocks are less likely to derail your plan. Spot future contenders early by reviewing the screener containing 22 high quality undiscovered gems that quietly combine solid metrics with less crowded ownership.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2639603100","isCrawlerRequest":true}